Kuijper, Steven C.
Cara, Irene
Geleijnse, Gijs
Slingerland, Marije
Nieuwenhuijzen, Grard A. P.
Lagarde, Sjoerd M.
Klarenbeek, Bastiaan R.
Kouwenhoven, Ewout A.
van Hillegersberg, Richard
Verhoeven, Rob H. A.
van Laarhoven, Hanneke W. M.
Article History
Received: 8 May 2025
Accepted: 10 December 2025
First Online: 3 February 2026
Declarations
:
: Marije Slingerland has acted as a consultant or advisory role for BMS, Astra Zeneca and Lilly. Rob Verhoeven has received research grants from Bristol Myers Squibb and performed consultancy for Daiichi Sankyo, all paid to the institute. Grard Nieuwenhuijzen has received research and consultancy grants by Medtronic. Ewout Kouwenhoven has received consultancy grants by Intuitive Surgical. Hanneke van Laarhoven has received research funding and/or medication supply from Amphera, Anocca, Astellas, AstraZeneca, Beigene, Boehringer, Daiichy-Sankyo, Dragonfy, MSD, Myeloid, ORCA, Servier; has had a consultant/advisory role for Auristone, Incyte, Merck, Myeloid, Servier; and was a speaker for Astellas, Beigene, Benecke, BMS, Daiichy-Sankyo, JAAP, Medtalks, Novartis, Springer, Travel Congress Management B.V. All other authors have no competing interests.